← Leaderboards
Jing Li
Bohemica Pharmaceuticals, Llc
$347,546
Attributed
$347,546
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$347,546 · 1
By mechanism
R41$347,546 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Anticancer Activity”
- David Heimbrook · Leidos Biomedical Research, Inc.$287,965,581
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$144,296,179
- Richard L Schilsky · University Of Chicago$115,233,315
- Peter J O'Dwyer · University Of Pennsylvania$85,010,063
- Philip J Disaia · University Of California Irvine$71,060,050
- Larry Arthur$64,615,803
Research focus
Anticancer ActivityBaseCancer TypeCharacteristicsChemokineChemokine ReceptorChemotherapyCholangiocarcinomaClinical ResearchCombined Modality TherapyComplexCxcr4 GeneDesignExhibitsFamilyFormulationGenerationsHistocompatibility TestingHuman DiseaseIncidenceInflammatoryInflammatory Bowel DiseasesInhibitor/AntagonistAdjuvant